Biostar Pharmaceuticals To Announce 2012 Second Quarter Financial Results On Tuesday, August 14th And Conduct Conference Call On Wednesday, August 15th

XIANYANG, China, Aug. 13, 2012 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that it will issue its financial results for the second quarter ended June 30, 2012 on Tuesday, August 14th after the close of the market. 

Biostar's Chairman and CEO, Ronghua Wang and CFO, Zack Pan will host a conference call on Wednesday, August 15, 2012 at 10:00 am E.T. to discuss these results as well as recent corporate developments.

Live conference call details
Interested parties may participate in the call by dialing (480) 629-9857.  Please call in 10 minutes before the conference is scheduled to begin and ask for the Biostar call or use pass code 4559554.  After opening remarks, there will be a question and answer period.  Questions may be asked during the live call, or alternatively, you may e-mail questions in advance to [email protected].

The conference call will also be broadcast live over the Internet.  To listen to the webcast, please go to or visit Biostar's website and then to the Event Calendar page where the conference call is posted.  Please go to the website at least 15 minutes early to register, and download and install any necessary audio software.  If you are unable to listen live, the conference call will be archived and can be accessed for approximately 90 days.  We suggest listeners use Microsoft Internet Explorer as their web browser.

A replay will be available until 11:59 pm E.T. on August 22, 2012. To listen, please call (858) 384-5517 and use pass code 4559554.

About Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. For more information please visit:

For more information contact:  

Biostar Pharmaceuticals, Inc.    

The Equity Group Inc.

Zack Pan, CFO                         

Lena Cati

Tel: 405-996-8829                       

Tel: 212 836-9611

Email: [email protected]             

Email: [email protected]  

SOURCE Biostar Pharmaceuticals, Inc.